Researchers from the Organoid group (former Clevers group, Hubrecht Institute) together with researchers from the Princess Máxima Center for pediatric oncology have established novel human organoid models of fatty liver ...
Feb 23, 2023
0
40
Being aware of a strong family history of prostate cancer is linked to an increased chance of surviving the disease, new research suggests.
Feb 13, 2023
0
2
Together with Philips and the Catharina Hospital in Eindhoven, TU/e has started a study on the use of smart plasters in the nursing ward. The researchers are looking at whether this innovative tool will allow nurses to spend ...
Feb 10, 2023
0
29
A new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs, according to a study published in the ...
Feb 9, 2023
0
1
Led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), an international group of the world's top clinicians in managing nasopharyngeal carcinoma ...
Feb 6, 2023
0
5
New data from a Yale Cancer Center-led clinical trial shows improved rates of survival and reduced risk of recurrence in patients taking osimertinib, a targeted therapy for non-small cell lung cancer (NSCLC). NSCLC is the ...
Jan 31, 2023
0
21
Several progressive neurodegenerative disorders, including Alzheimer's disease, are defined by having tau proteins in the brain. Researchers are seeking to identify the mechanisms behind these tau proteins to develop treatments, ...
Jan 31, 2023
0
100
In an internationally conducted clinical trial lead by Dana-Farber involving patients with recurrent ovarian cancer that is resistant to platinum therapy, a novel conjugate therapy called mirvetuximab soravtansine resulted ...
Jan 31, 2023
0
73
Josep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase III SUNLIGHT study during an Oral Abstract Session at this week's American Society of Clinical Oncology's ...
Jan 23, 2023
0
8
Older Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in the last weeks of life, according to a study led by investigators at Harvard-affiliated ...
Jan 18, 2023
0
10
